ScholarIQanswers from OpenAlex

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer

PaperCitations, authors & open-access status

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer have?

ScholarIQcitation count

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer has 111 citations in the OpenAlex counts ScholarIQ stores.

When was Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer published?

ScholarIQyear

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer has 2019 year in the ScholarIQ index.

What is the open-access status of Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer?

ScholarIQoa status

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer has gold oa status in the ScholarIQ index.

What is the DOI of Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer?

ScholarIQdoi

The DOI for Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer is on the source record.

What is the PMID of Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer?

ScholarIQpmid

The PMID for Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer is on the source record.

What is the OpenAlex record for Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer?

ScholarIQopenalex

The OpenAlex for Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial